Noven Pharmaceuticals, Inc.
 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (date of earliest event reported): October 29, 2003

Noven Pharmaceuticals, Inc.

11960 S.W. 144th Street, Miami, Florida 33186

305-253-5099

         
Incorporated under the laws of the   Commission File Number   I.R.S. Employer Identification Number
State of Delaware   0-17254   59-2767632

 

 

Item 7. Exhibits

     (c)  Exhibits.

     
99.1   Press release dated October 29, 2003.

Item 12. Results of Operations and Financial Condition

     On October 29, 2003, Noven Pharmaceuticals, Inc. (the “Company”) issued a press release announcing matters expected to impact its financial results for the quarter ended September 30, 2003. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

2

 

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

     
    NOVEN PHARMACEUTICALS, INC.
 
 
    /s/ Jeffrey F. Eisenberg
   
    Jeffrey F. Eisenberg
Vice President, General Counsel and
Corporate Secretary

Date: October 29, 2003

3

 

INDEX TO EXHIBITS

     
Exhibit No   Description
 
99.1   Press Release, dated October 29, 2003

4